PARP1 and cancer: Given PARP1 pleiotropic roles in aging, inflammation, degeneration and cancer [59–61], these systems may provide useful reagents for the future development of PARP inhibitors and other drugs that target innate immune signaling for the prevention and/or treatment of these disorders.